Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug?

Front Immunol. 2023 Jun 8:14:1183665. doi: 10.3389/fimmu.2023.1183665. eCollection 2023.

Abstract

Acute immuno-depression syndrome (AIDs) had been observed in many life-threatening conditions leading to the Intensive Care Unit. and is associated with recurrent secondary infections. We report one COVID-19 patient with a severe ARDS, demonstrating acute immunodepression syndrome lasting for several weeks. The occurrence of secondary infections despite long treatment by antibiotics led to combined interferon γ (IFNγ) as reported previously. The response to IFNγ was evaluated by the flowcytometry HLA-DR expression on circulating monocytes, which was repeated from time to time. The severe COVID-19 patients responded well to IFNγ without adverse events.

Keywords: ARDS (acute respiratory disease syndrome); COVID 19; HLA-DR; acute immuno-depression syndrome; interferon gamma (IFNγ).

Publication types

  • Case Reports

MeSH terms

  • COVID-19*
  • Coinfection* / drug therapy
  • HLA-DR Antigens / metabolism
  • Humans
  • Immune Tolerance
  • Interferon-gamma / pharmacology

Substances

  • Interferon-gamma
  • HLA-DR Antigens